Molecular Pharming is on the brink of taking off! After two decades of development and academic proofs of principle, a number of recent advances have moved the technology rapidly towards commercialisation. The first products are now being licensed in the USA. The first-in-human clinical trial of a plant derived monoclonal antibody has been performed in Europe. And there has been significant investment into manufacturing facilities around the world.

This meeting will review the progress of the field, highlight major technological advances and scan the horizon for future developments.   

Professor Julian Ma, St Georges Hospital-University London

Dr Pascal Drake, St. George's, University of London 

Professor Maurice Moloney, Rothamsted Research Ltd, United Kingdom 

Professor Diego Orzaez, Instituto de Biologia Molecular y Celular de Plantas-CSIC, Valencia, Spain  

Professor George Lomonossoff , John Innes Centre, UK